HSI Lunch Seminar Series Scale Up Health Part 1: Exiting Startup - Fuel Up
E62-350
100 Main Street, Cambridge, MA United States
Details
The Scale Up Health Series explores the concept of "scaling in healthcare", bringing together industry operators who have successfully scaled healthcare solutions with strategic and financial investors to discuss the challenges and opportunities in healthcare scaling.
Exiting Startup - Fuel Up
Explores challenges and strategies for transitioning from startup to growth stage.
Monday November 4, 2024
Location: E62-350
Time: 11:30am - 1pm
RSVP at Sloan Groups *Open to All*
Lunch will be provided in person.
Join Zoom Meeting
If manually joining the meeting:
Meeting ID: 926 8616 4245
Passcode: 15777
Moderators:
Rebecca L. Schechter, MBA '96, Formerly at Nuance/Microsoft, Healthcare executive and CEO
Eric Berger, MBA '11, Partner, Bain & Company
Speakers:
Deepthi Bathina, Founder and CEO, RhythmX AI
Ellen Herlacher, MBA '13, Partner, LRVHealth
Vijay J. Patel, MBA '12, Managing Partner, CVS Health Ventures
Deepthi Bathina, Founder and CEO, RhythmX AI
She has held CEO and COO positions and led global operations at multiple high growth companies where she scaled businesses across various inflection points ranging from millions to billions within start-ups and Fortune 50 companies. Deepthi Bathina is currently the founder and CEO of RhythmX AI. With $50M initial investment, RhythmX AI, based out of the silicon valley, is a generative AI-native health company driving a paradigm shift in hyper-personalized care.
Bathina is chair of the board of the Kerry Murphy Healey Center for Health Innovation and Entrepreneurship at Babson College.
She is the former chief product officer at Humana, a Fortune 50 healthcare firm, where she led product development and management of all healthcare solutions for the entire company and led customer success functions including implementations across Medicare, Medicaid, and commercial segments.
Before Humana, Bathina was general manager of operations for the $1 billion Healthcare Technology Division of Nuance Communications.
She is the former head of global operations for the clinical decision support division (UpToDate) at Wolters Kluwer, leading global customer operations in 170 countries.
Ellen Herlacher, MBA '13, Partner, LRVHealth
She is a healthcare investor with a deep background in investment management, healthcare operations, and corporate strategy.
As Partner at LRVHealth, Ellen co-leads the firm’s research and investments in new care delivery, behavioral health, workforce transformation, and government sponsored payers. In this role, she led LRVHealth’s investments in Diana Health, a reimagined maternity care company, and Cortica, a physician-led, whole-child, value-based autism services company. She also supports the firm’s investments in Reimagine Care, Huddle Up, Greater Good Health, and Season. Before joining LRVHealth in 2020, Ellen was director of Tufts Health Ventures, the corporate development and corporate investment arm of Tufts Health Plan (now Point32 Health). Prior to joining Tufts, she held management roles at athenahealth and investment and consulting roles at Goldman Sachs and Bain & Company.
Ellen earned a B.A. from Cornell University and M.B.A. from Massachusetts Institute of Technology.
Vijay J. Patel, MBA '12, Managing Partner, CVS Health Ventures
He is the Vice President and Managing Partner of CVS Health Ventures. Vijay leads CVS Health’s venture investment program, which encompasses limited partner investments, a dedicated corporate venture fund, minority growth equity strategy and a market development function that partners with high-potential, early-stage companies.
Prior to his current role, Vijay led the Enterprise Business Development team and was a member of the CVS Health COVID-19 Task Force responsible for structuring partnerships to support testing and vaccination efforts. He joined the company’s Boston Digital Innovation Lab in 2015, where he led our efforts to develop strategic partnerships with investments in digital health and technology companies. Vijay also founded the CVS Digital Leadership Program to attract and retain early career talent.
Prior to joining CVS Health, Vijay worked as an investment professional at H.I.G. Growth Partners and Bain Capital.
Vijay earned a bachelor’s degree from the Jerome Fisher Program in Management and Technology at the University of Pennsylvania and an MBA from the MIT Sloan School of Management.
Future Sessions:
Tuesday February 11, 2025
Part 2 - Scaling: Ramp Up
Discuss key factors and best practices for successful scaling in healthcare.
Tuesday April 29, 2025
Part 3 - Exiting and Transforming: Level Up
Examine strategies for exiting or transforming scaled healthcare enterprises.
Speakers
Rebecca L. Schechter, MBA '96
Healthcare executive and CEO
Formerly at Nuance/Microsoft
https://www.linkedin.com/in/rebecca-schechter/
With over 25 years of experience in building and transforming businesses at scale across healthcare and financial services, she is a passionate end to end P&L leader/CEO having led business with revenue of $250M to $6B., investor, and advisor who leverages technology to improve outcomes for all.
Most recently, as the SVP and General Manager of DAX, Nuance's market-leading healthcare GenAI SaaS solution, she led a team of talented professionals committed to transforming the clinician-patient experience with the latest advancements in conversational AI, ambient intelligence, and generative AI. Prior to that, she was the CEO of Optum Behavioral Health and held President and C-Suite roles at Liberty Mutual and State Street.
She is a Board Director at iA Financial Group, where she contributes to the risk, governance, and ethics oversight of one of Canada's largest insurance and wealth management companies. As a Venture Partner at Nina Capital, a global healthtech venture fund, she supports early-stage startups that are developing cutting-edge solutions in digital health, medtech, biotech, and wellness. She is also an advisor to global Private Equity Investors in healthcare/technology.
Her core competencies include driving transformative plays at scale, delivering profitable growth with a proven track record in highly competitive and regulated markets. She has an MBA from MIT Sloan, and has lived, worked and studied across Europe, North America and Asia.
Eric Berger
Partner
Bain & Company
https://www.linkedin.com/in/eric-berger-48367215/
Eric Berger is a member of Bain’s Healthcare & Life Sciences and Private Equity practices with more than 10 years of consulting experience.
Eric advises clients across a range of industries, with a focus in private equity funds as well as healthcare payers and services and biotech / pharma. He has additional experience in industrial goods and services and consumer packaged goods.
He holds expertise in topics related to commercial due diligence, business unit strategy, operating model, organization design, pricing, brand strategy and mergers & acquisitions.
Prior to joining Bain in 2011, Eric worked for a small consulting firm in Boston focused on the pharmaceutical, biotech and medical device industries. Previously, he was a researcher in organic chemistry at Harvard University. Eric has published in Science and the Journal of the American Chemical Society and was awarded a grant from the Howard Hughes Medical Institute and the Jean Dreyfus Boissevain scholarship.
Eric earned an MBA from MIT Sloan School of Management. He holds a BA cum laude and MA in chemistry from Harvard University.
Deepthi Bathina
Founder and CEO
RhythmX AI
https://www.linkedin.com/in/deepthibathina
Deepthi Bathina has held CEO and COO positions and led global operations at multiple high growth companies where she scaled businesses across various inflection points ranging from millions to billions within start-ups and Fortune 50 companies. Deepthi Bathina is currently the founder and CEO of RhythmX AI. With $50M initial investment, RhythmX AI (https://rhythmx.ai/, based out of the silicon valley, is a generative AI-native health company driving a paradigm shift in hyper-personalized care.
Bathina is chair of the board of the Kerry Murphy Healey Center for Health Innovation and Entrepreneurship at Babson College.
She is the former chief product officer at Humana, a Fortune 50 healthcare firm, where she led product development and management of all healthcare solutions for the entire company and led customer success functions including implementations across Medicare, Medicaid, and commercial segments.
Before Humana, Bathina was general manager of operations for the $1 billion Healthcare Technology Division of Nuance Communications.
She is the former head of global operations for the clinical decision support division (UpToDate) at Wolters Kluwer, leading global customer operations in 170 countries.
Ellen Herlacher
Partner
LRVHealth
https://www.linkedin.com/in/ellenherlacher/
Ellen Herlacher is a healthcare investor with a deep background in investment management, healthcare operations, and corporate strategy.
As Partner at LRVHealth, Ellen co-leads the firm’s research and investments in new care delivery, behavioral health, workforce transformation, and government sponsored payers. In this role, she led LRVHealth’s investments in Diana Health, a reimagined maternity care company, and Cortica, a physician-led, whole-child, value-based autism services company. She also supports the firm’s investments in Reimagine Care, Huddle Up, Greater Good Health, and Season. Before joining LRVHealth in 2020, Ellen was director of Tufts Health Ventures, the corporate development and corporate investment arm of Tufts Health Plan (now Point32 Health). Prior to joining Tufts, she held management roles at athenahealth and investment and consulting roles at Goldman Sachs and Bain & Company.
Ellen earned a B.A. from Cornell University and M.B.A. from Massachusetts Institute of Technology.
Vijay J. Patel
Managing Partner
CVS Health Ventures
https://www.linkedin.com/in/vpatel1/
Vijay Patel is the Vice President and Managing Partner of CVS Health Ventures. Vijay leads CVS Health’s venture investment program, which encompasses limited partner investments, a dedicated corporate venture fund, minority growth equity strategy and a market development function that partners with high-potential, early-stage companies.
Prior to his current role, Vijay led the Enterprise Business Development team and was a member of the CVS Health COVID-19 Task Force responsible for structuring partnerships to support testing and vaccination efforts. He joined the company’s Boston Digital Innovation Lab in 2015, where he led our efforts to develop strategic partnerships with investments in digital health and technology companies. Vijay also founded the CVS Digital Leadership Program to attract and retain early career talent.
Prior to joining CVS Health, Vijay worked as an investment professional at H.I.G. Growth Partners and Bain Capital.
Vijay earned a bachelor’s degree from the Jerome Fisher Program in Management and Technology at the University of Pennsylvania and an MBA from the MIT Sloan School of Management.
Anne Quaadgras
Director
MIT Sloan Health Systems Initiative
https://www.linkedin.com/in/anne-quaadgras-6208778/
Anne Quaadgras is the Director of the MIT Sloan Health Systems Initiative and a Senior Lecturer at MIT Sloan.
Her work focuses on health systems transformation, and the role of information technology in supporting that change.
Prior to her doctoral work, Anne was a management consultant for fifteen years, specializing in improving decision-making and investment processes in the chemical, pharmaceutical, and financial services industries.
She holds a Bachelor’s and Master’s degree in chemical engineering from MIT. Anne earned her doctorate in information systems at Boston University, where her dissertation research explored how globally distributed groups of experts recognize and respond to operational problems.